Abstract

1. Abstract
1.1. Background: Even after curative surgery, the prognosis for patients with localised pancreatic cancer is still poor. The most often utilised serum-based tumour marker for the detection and monitoring of pancreatic cancer is Carcinoembryonic Antigen (CEA).
1.2. Objective: To investigate the use of Carcinoembryonic Antigen (CEA) as prognostic factors in localized pancreatic adenocarcinoma patients.